Logo

Simulating for Safety

Dec 17, 2008

The Wall Street Journal reports that FDA will be using simulations to try to identify safety and effectiveness problems in drugs under development. The simulation technology, developed by Entelos, will be used to test three drugs under investigation for heart-related conditions. "The agreement is part of a broader effort by the FDA to get an earlier read on the safety and efficacy of new drugs and to identify the characteristics of patients that lead some to benefit from a drug while others are at risk of a bad outcome," says the article.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.